OTC Pharmaceuticals in South Korea

Datamonitor's OTC Pharmaceuticals in South Korea industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of OTC Pharmaceuticals in South Korea’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of OTC Pharmaceuticals in South Korea

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by both value and volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

* Market shares are covered by manufacturer and/or brand

* Also features market breakdown by distribution channel

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purposes of this report, Asia-Pacific comprises Australia, China, India, Japan, Singapore, South Korea, and Taiwan.

[Cerrar las informaciones del articulo de mercado]

TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
MARKET OVERVIEW 7
Market definition 7
Research highlights 8
Market analysis 9
MARKET VALUE 10
MARKET SEGMENTATION I 11
MARKET SEGMENTATION II 12
MARKET SHARE 13
FIVE FORCES ANALYSIS 14
Summary 14
Buyer power 16
Supplier power 17
New entrants 18
Substitutes 20
Rivalry 21
LEADING COMPANIES 22
Dong Wha Pharmaceutical Industrial Co. Ltd. 22
Johnson & Johnson 24
Whanin Pharmaceuticals Co. Ltd. 29
MARKET DISTRIBUTION 33
MARKET FORECASTS 34
Market value forecast 34
MACROECONOMIC INDICATORS 35
APPENDIX 37
Methodology 37
Industry associations 38
Related Datamonitor research 38
Disclaimer 40
ABOUT DATAMONITOR 41
Premium Reports 41
Summary Reports 41
Datamonitor consulting 41

LIST OF TABLES
Table 1: South Korea OTC pharmaceuticals market value: $ million, 2005–09 10
Table 2: South Korea OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Table 3: South Korea OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Table 4: South Korea OTC pharmaceuticals market share: % share, by value, 2009 13
Table 5: Dong Wha Pharmaceutical Industrial Co. Ltd.: key facts 22
Table 6: Johnson & Johnson: key facts 24
Table 7: Johnson & Johnson: key financials ($) 26
Table 8: Johnson & Johnson: key financial ratios 27
Table 9: Whanin Pharmaceuticals Co. Ltd.: key facts 29
Table 10: Whanin Pharmaceuticals Co. Ltd.: key financials ($) 30
Table 11: Whanin Pharmaceuticals Co. Ltd.: key financials (KRW) 30
Table 12: Whanin Pharmaceuticals Co. Ltd.: key financial ratios 31
Table 13: South Korea OTC pharmaceuticals market distribution: % share, by value, 2009 33
Table 14: South Korea OTC pharmaceuticals market value forecast: $ million, 2009–14 34
Table 15: South Korea size of population (million), 2005–09 35
Table 16: South Korea gdp (constant 2000 prices, $ billion), 2005–09 35
Table 17: South Korea gdp (current prices, $ billion), 2005–09 35
Table 18: South Korea inflation, 2005–09 36
Table 19: South Korea consumer price index (absolute), 2005–09 36
Table 20: South Korea exchange rate, 2005–09 36

LIST OF FIGURES
Figure 1: South Korea OTC pharmaceuticals market value: $ million, 2005–09 10
Figure 2: South Korea OTC pharmaceuticals market segmentation I:% share, by value, 2009 11
Figure 3: South Korea OTC pharmaceuticals market segmentation II: % share, by value, 2009 12
Figure 4: South Korea OTC pharmaceuticals market share: % share, by value, 2009 13
Figure 5: Forces driving competition in the OTC pharmaceuticals market in South Korea, 2009 14
Figure 6: Drivers of buyer power in the OTC pharmaceuticals market in South Korea, 2009 16
Figure 7: Drivers of supplier power in the OTC pharmaceuticals market in South Korea, 2009 17
Figure 8: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in South Korea, 2009 18
Figure 9: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in South Korea, 2009 20
Figure 10: Drivers of degree of rivalry in the OTC pharmaceuticals market in South Korea, 2009 21
Figure 11: Johnson & Johnson: revenues & profitability 27
Figure 12: Johnson & Johnson: assets & liabilities 28
Figure 13: Whanin Pharmaceuticals Co. Ltd.: revenues & profitability 31
Figure 14: Whanin Pharmaceuticals Co. Ltd.: assets & liabilities 32
Figure 15: South Korea OTC pharmaceuticals market distribution: % share, by value, 2009 33
Figure 16: South Korea OTC pharmaceuticals market value forecast: $ million, 2009–14 34


[Cerrar la tabla de contenidos]